Cargando…
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Currently approved COVID-19 vaccines administered parenterally induce robust systemic humoral and cellular responses. While highly effective against severe disease, there is reduced effectiveness of these vaccines in preventing breakthrough infection and/or onward transmission, likely due to poor im...
Autores principales: | Pilapitiya, Devaki, Wheatley, Adam K., Tan, Hyon-Xhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154910/ https://www.ncbi.nlm.nih.gov/pubmed/37146404 http://dx.doi.org/10.1016/j.ebiom.2023.104585 |
Ejemplares similares
-
Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021) -
SARS-CoV-2 vaccines: a triumph of science and collaboration
por: Golob, Jonathan L., et al.
Publicado: (2021) -
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Tan, Hyon-Xhi, et al.
Publicado: (2021) -
The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
por: Loke, Justin, et al.
Publicado: (2019) -
Triumph of hope over experience: learning from interventions to reduce avoidable hospital admissions identified through an Academic Health and Social Care Network
por: Woodhams, Victoria, et al.
Publicado: (2012)